Abbonarsi

Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors - 13/08/11

Doi : 10.1016/j.jaad.2010.06.020 
Beatriz Llombart, MD a, d, , Carlos Monteagudo, MD d, Onofre Sanmartín, MD a, José Antonio López-Guerrero b, Carlos Serra-Guillén, MD a, Andrés Poveda, MD c, Esperanza Jorda, MD e, Antonio Fernandez-Serra b, Antonio Pellín, MD d, Carlos Guillén, MD a, Antonio Llombart-Bosch, MD d
a Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain 
b Department of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain 
c Department of Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain 
d Department of Pathology, Hospital Clínico Universitario, Valencia, Spain 
e Department of Dermatology, Hospital Clínico Universitario, Valencia, Spain 

Reprint requests: Beatriz Llombart, MD, Department of Dermatology, Instituto Valenciano de Oncología, C/Profesor Beltrán Báguena, 4. 46009 Valencia, Spain.

Abstract

Background

Dermatofibrosarcoma protuberans (DFSP) is an uncommon cutaneous tumor, usually low grade, except for the fibrosarcomatous variant (DFSP-FS).

Objectives

We sought to compare the clinicopathological, immunohistochemical, genetic, and therapeutic features between DFSP and DFSP-FS.

Methods

The clinicopathological features were reviewed in 63 DFSP and 12 DFSP-FS. Immunohistochemistry and multiplex reverse transcriptase-polymerase chain reaction were carried out using formalin-fixed, paraffin-embedded tissue, using specific primers for collagen type I alpha 1 (COL1A1) and platelet-derived growth factor beta (PDGFB).

Results

DFSP-FS was associated with tumor history longer than 5 years (P = .009), tumor size greater than 4 cm (P = .001), more stages of modified Mohs micrographic surgery (P = .005), expansive subcutaneous infiltration (P = .005), muscular invasion (P = .0001), absence of CD34 staining (P = .018), p53 positivity (P = .006), and increased proliferative activity (P = .004) compared with DFSP. The COL1A1-PDGFB fusion transcript was found in 100% DFSP-FS and 72% DFSP. No association was found between the different COL1A1-PDGFB fusion transcripts and the different histologic subtypes. Wide local excision (2 cm) was performed in 47% of cases and modified Mohs micrographic surgery in 53%. After a mean follow-up of 73 months (range 21-235), 6 patients had local recurrence (5 DFSP, 1 DFSP-FS) and one died of disease (DFSP-FS). The only factor related to local recurrence was the type of surgery (17% wide local excision vs 0% modified Mohs micrographic surgery) (P = .006).

Limitations

Our study is retrospective. Prospective studies are necessary to confirm our results.

Conclusions

DFSP-FS reflects tumor progression in DFSP, with larger size, particular invasive patterns, p53 expression, and increased proliferative activity. However, as in low-grade DFSP, appropriate surgery permits a tumor-free excision. COL1A1-PDGFB is a useful tool for diagnosis of DFSP and particularly for DFSP-FS.

Il testo completo di questo articolo è disponibile in PDF.

Key words : collagen type I alpha 1–platelet-derived growth factor beta, dermatofibrosarcoma protuberans, fibrosarcomatous, Ki-67, Mohs micrographic surgery, p53, wide local excision

Abbreviations used : COL1A1, DFSP, DFSP-FS, MMS, PCR, PDGFB, WLE


Mappa


 Supported by Fomación en Investigación en Salud grant P1040822 and grant GV06/274 from the Consellería de Educación y Ciencias (Generalitat Valenciana).
 Conflicts of interest: None declared.


© 2010  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 65 - N° 3

P. 564-575 - settembre 2011 Ritorno al numero
Articolo precedente Articolo precedente
  • Skin blood flow abnormalities in diabetic dermopathy
  • Alexandra Brugler, Shaun Thompson, Scott Turner, Binh Ngo, Marc Rendell
| Articolo seguente Articolo seguente
  • Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications
  • Jeremy S. Bordeaux, Kathryn J. Martires, Dori Goldberg, Sean F. Pattee, Pingfu Fu, Mary E. Maloney

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.